Mariner, LLC Meridian Bioscience Inc Transaction History

Mariner, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$31.15 - $33.39 $3,800 - $4,073	122 Added 0.49%	24,795 $823,000
Q3 2022 Nov 10, 2022	SELL	$30.9 - $33.55 $2,163 - $2,348	-70 Reduced 0.28%	24,673 $778,000
Q2 2022 Aug 15, 2022	BUY	$23.75 - $31.69 $13,371 - $17,841	563 Added 2.33%	24,743 $752,000
Q1 2022 May 13, 2022	BUY	$19.97 - $26.94 $231,592 - $312,423	11,597 Added 92.16%	24,180 $628,000
Q4 2021 Feb 14, 2022	SELL	$17.46 - $21.61 $28,058 - $34,727	-1,607 Reduced 11.32%	12,583 $257,000
Q3 2021 Nov 15, 2021	SELL	$17.35 - $22.5 $8,692 - $11,272	-501 Reduced 3.41%	14,190 $273,000
Q2 2021 Aug 24, 2021	BUY	$18.01 - $28.32 $7,438 - $11,696	413 Added 2.89%	14,691 $326,000
Q1 2021 May 07, 2021	SELL	$19.76 - $29.89 $16,143 - $24,420	-817 Reduced 5.41%	14,278 $375,000
Q4 2020 Feb 16, 2021	BUY	$15.73 - $21.66 $35,093 - $48,323	2,231 Added 17.34%	15,095 $282,000
Q2 2020 Aug 14, 2020	BUY	$7.84 - $23.29 $100,853 - $299,602	12,864 New	12,864 $300,000
Q1 2019 May 15, 2019	SELL	$15.51 - $17.61 $528,131 - $599,638	-34,051 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$14.52 - $19.72 $494,420 - $671,485	34,051 New	34,051 $591,000

113K

Ticker VIVO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 43,748,000
Description
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

Stay updated on Mariner, LLC with notifications on news.